• Rifampin Workflows for Transcription Research

  2026-09-17

  Rifampin is a mechanism-defined rifamycin antibiotic for dissecting bacterial transcription, resistance, and synthetic biology circuits. This practical guide covers stock preparation, exposure design, controls, data interpretation, and troubleshooting for reproducible bench workflows.

• HotStart™ Universal 2X Green qPCR Master Mix

  2026-09-16

  A scenario-based guide to using HotStart™ Universal 2X Green qPCR Master Mix (SKU K1170) for gene expression follow-up in cell viability, proliferation, and cytotoxicity studies. It addresses assay variability, inhibitor control, melt curve analysis, data normalization, and practical vendor selection.

• MK-0812 and the Gut–Liver Axis in MASH Research

  2026-09-16

  A translational framework for using MK-0812 to test whether CCR2-dependent monocyte trafficking connects intestinal dysfunction with hepatic inflammation in MASH models.

• 10 mM dNTP Mixture for PCR and LNP Workflows

  2026-09-15

  The 10 mM dNTP mixture provides an equimolar, pH 7.0 source of dATP, dCTP, dGTP, and dTTP for reproducible PCR, qPCR, sequencing, and DNA-template preparation. Its practical value extends to nucleic acid delivery studies, where consistent DNA synthesis helps isolate how LNP surface charge and target-cell state influence functional delivery.

• Thymoquinone Protects Against Doxorubicin Cardiotoxicity

  2026-09-15

  A 2025 study found that thymoquinone reduced doxorubicin-associated cardiac injury in mice, with protection linked to Nrf2/HO-1 activation, improved antioxidant status, and attenuation of ferroptosis-related damage. Its integrated cardiovascular, biochemical, immunohistochemical, and ultrastructural design provides a useful framework for studying cardiotoxicity mitigation while emphasizing that anticancer efficacy must be evaluated separately.

• AMG 9810: TRPV1 Antagonist Workflow Guide

  2026-09-14

  Build cleaner calcium-imaging and CGRP assays with AMG 9810, a selective competitive TRPV1 antagonist that supports stimulus-specific pain mechanism research. This guide connects practical sensory-neuron workflows with metabolic-stress controls inspired by recent AMPK–SQSTM1 findings.

• FPS-ZM1 and the RAGE/POMC Bridge

  2026-09-14

  A translational perspective on how FPS-ZM1 can test RAGE-dependent amyloid beta signaling, neuroinflammation, and hypothalamic RAGE/POMC biology while keeping preclinical evidence distinct from therapeutic claims.

• NF 449 for Reliable Platelet Assays

  2026-09-13

  NF 449 (SKU B6716) is a potent purinergic receptor antagonist for experimentally separating P2X1-mediated platelet signaling from broader ATP and ADP responses. This scenario-based guide explains assay selection, concentration interpretation, handling, controls, and practical vendor evaluation using published quantitative evidence.

• Oltipraz Workflows for Nrf2 and MASLD Research

  2026-09-12

  Oltipraz provides a defined small-molecule approach for linking Nrf2-dependent phase II enzyme induction with autophagy, ferroptosis, and liver-injury assays. This article translates recent MASLD findings into practical dose-finding, readout-selection, troubleshooting, and mechanistic validation workflows.

• Cisplatin (CDDP) Workflows for Chemoresistance

  2026-09-11

  Use Cisplatin (CDDP) as a controlled DNA-damage challenge to connect cell killing with apoptosis, oxidative stress, and chemoresistance mechanisms. This workflow translates the ZNF263–STAT3 findings in colorectal cancer into practical assay designs for viability testing, resistance profiling, and tumor growth inhibition in xenograft models.

• Intestinal TM6SF2 and MASH: Gut–Liver Axis Evidence

  2026-09-11

  The reference study identifies intestinal epithelial TM6SF2 as a protective regulator of MASH and connects its loss to barrier failure, microbial dysbiosis, and gut-derived lysophosphatidic acid signaling. Conditional genetics, fecal transplantation, co-housing, and receptor inhibition together provide a mechanistic framework for studying host–microbe contributions to steatohepatitis.

• Sodium chloride: Buffer Preparation and QC

  2026-09-10

  Sodium chloride is an inorganic salt used to set ionic strength and support osmotic balance in aqueous buffers, biochemical assays, and cell culture media workflows. This guide covers preparation, storage, and QC boundaries while clarifying that the reagent should be dissolved in water rather than DMSO or ethanol and should not be treated as a sterility-qualified or pH-buffering material.

• Reparixin: A CXCR1/2 Lens on IL-8 Biology

  2026-09-10

  Reparixin is a CXCR1/2 inhibitor that enables receptor-level analysis of IL-8 signaling across neutrophil, tissue-injury, and tumor models. This article translates recent MRSA extracellular-vesicle findings into practical assay decisions while distinguishing established evidence from proposed applications.

• From Cassava Stress Genes to Translational PCR Strategy

  2026-09-09

  A mechanistic and strategic guide to using endpoint PCR to validate stress-response genes, support TA cloning, and build more reproducible translational workflows around cassava A20/AN1 research.

• Cyclophosphamide: From Bioactivation to Assay Design

  2026-09-09

  Cyclophosphamide is an alkylating chemotherapeutic agent whose hepatic bioactivation makes experimental interpretation highly dependent on model context. This guide connects DNA damage biology, topotecan-based mechanistic insight, immune endpoints, and reproducible assay design.

8103 records 1/541 page Next 12345 下5页 Last page